Thomas Vorherr

Director Peptide Discovery

Novartis (Basel, Switzerland)


Director Peptide Discovery at Novartis (Basel, Switzerland) February 2011 – Present: Development of peptide therapeutics using internal and external resources. BD Bachem Group at Bachem Holding AG (Bubendorf, Switzerland) 2002 – February 2011: M & A, evaluation of new strategies & technologies (BD), licensing. Member of the research board. Director Biochemicals at Bachem AG (Bubendorf, Switzerland) 1997 – 2002: Head of the department Biochemicals. Custom synthesis, new product development and production for the Bachem catalogue. Member of the research board. Managing Director at Amplimmun (Madulain, Switzerland) 1996 – 1997: Head of development and production of a diagnostic biotech company originating from ‘Gemeinschaftspraxis Labor Prof. Seelig & Kollegen’ (Karlsruhe, Germany). Assays and cGMP oligonucleotide synthesis. Laboratory Leader in Pharma Research at Hoffmann La-Roche (Basel, Switzerland) 1992 – 1996: Collaboration on pharma-projects regarding peptide and combinatorial chemistry. Research Assistant at Swiss Federal Institute of Technology (Zurich, Switzerland) 1987 – 1992: Research in Biochemistry on Ca-binding proteins in the group of Prof. Dr. Ernesto Carafoli. Initiation of a core facility for Edman-sequencing, sequencing by mass-spectroscopy, and peptide synthesis. PhD in Organic Chemistry at the University of Basel (Basel, Switzerland) 1983 – 1987: Peptide synthesis, CAD and conformational studies in the group of Prof. Dr. Manfred Mutter Diploma in Organic Chemistry at the Johannes Gutenberg University (Mainz, Germany) 1976 – 1982: Diploma studies on a peptidic enzyme model for α-Chymotrypsin in the group of Prof. Dr. Manfred Mutter.